Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression

Journal of Reproductive Immunology

Volumn 84, Issue 2, 2010, Pages 199-205

  Velasco, Irene ^a,c   Acién, Pedro ^a,c   Campos, Adolfo ^a,b   Acién, María Isabel ^a,c   Ruiz Maciá, Eva ^a,c  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b Blood Bank Centre of Alicante   (Spain)

^c HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

Author keywords

'Chocolate' cyst fluid; Aromatase; Endometriosis; IL 6; Pain; Peritoneal fluid

Indexed keywords

AROMATASE; CA 125 ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ARTICLE; CELL POPULATION; CONTROLLED STUDY; CYST FLUID; DISEASE ASSOCIATION; ENDOMETRIOSIS; ENDOMETRIUM TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVARY CYST; OVARY TUMOR; PATHOPHYSIOLOGY; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE RISK; UTERUS SURGERY;

ADULT; AROMATASE; ASCITIC FLUID; CA-125 ANTIGEN; DYSMENORRHEA; ENDOMETRIOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-6; MIDDLE AGED; PELVIC PAIN; RECURRENCE;

EID: 76749168008     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.11.004     Document Type: Article

References (37)

1. Acién P., Quereda F.J., Gómez-Torres M.J., Bermejo R., and Gutiérrez M. GnRH analogues, transvaginal ultrasound-guided drainage and intracystic injection of recombinant interleukin-2 in the treatment of endometriosis. Gynecol. Obstet. Invest. 55 (2003) 95-103
2. Acién P., Pérez-Albert G., Quereda F., Sánchez-Ferrer M., García-Almela A., and Velasco I. Treatment of endometriosis with transvaginal ultrasound-guided drainage under GnRH analogues and recombinant interleukin-2 left in the cysts. Gynecol. Obstet. Invest. 60 (2005) 224-231
3. Acién P., Velasco I., Gutiérrez M., and Martínez-Beltrán M. Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings. Fertil. Steril. 88 (2007) 32-38
4. Akoum A., Lawson C., McColl S., and Villeneuve M. Ectopic endometrial cells express high concentrations of interleukin (IL)-8 in vivo regardless of the menstrual cycle phase and respond to oestradiol by up-regulating IL-1-induced IL-8 expression in vitro. Mol. Hum. Reprod. 7 (2001) 859-866
5. Amaral V.F., Ferriani R.A., Sá M.F., Nogueira A.A., Rosa e Silva J.C., Rosa e Silva A.C., et al. Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis. Sao Paulo Med. J. 124 (2006) 223-227
6. American Society for Reproductive Medicine. Revised American Society for Reproductive Medicine classification of endometriosis. Fertil. Steril. 67 (1996) 817-821
7. Arici A., Seli E., Zeyneloglu H.B., Senturk L.M., Oral E., and Olive D.L. Interleukin-8 induces proliferation of endometrial stromal cells: a potential autocrine growth factor. J. Clin. Endocrinol. Metab. 83 (1998) 1201-1205
8. Bedaiwy M.A., Falcone T., Sharma R.K., Goldberg J.M., Attaran M., Nelson D.R., et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum. Reprod. 17 (2002) 426-431
9. Bedaiwy M.A., El-Nashar S.A., Sharma R.K., and Falcone T. Effect of ovarian involvement on peritoneal fluid cytokine concentrations in endometriosis patients. Reprod. Biomed. Online 14 (2007) 620-625
10. Bulmer J.N., Jones R.K., and Searle R.F. Intraepithelial leukocytes in endometriosis and adenomyosis: comparison of eutopic and ectopic endometrium with normal endometrium. Hum. Reprod. 13 (1998) 2910-2915
11. Colette S., Lousse J.C., Defrère S., Curaba M., Heilier J.F., Van Langendonckt A., et al. Absence of aromatase protein and mRNA expression in endometriosis. Hum. Reprod. 24 (2009) 2133-2141
12. Edwards R.R., Kronfli T., Haythornthwaite J.A., Smith M.T., McGuire L., and Page G.G. Association of catastrophizing with interleukin-6 responses to acute pain. Pain 140 (2008) 135-144
13. Falconer H., Bambra C.S., Chai D., Cornillie F.J., Hill J.A., and D'Hooghe T.M. The effect of endometriosis, cycle stage, lymphocyte suppression and pregnancy on CA-125 levels in peritoneal fluid and serum in baboons. Hum. Reprod. 20 (2005) 3033-3038
14. Gallinelli A., Chiossi G., Giannella L., Marsella T., Genazzani A.D., and Volpe A. Different concentrations of interleukins in the peritoneal fluid women with endometriosis: relationship with lymphocyte subsets. Gynecol. Endocrinol. 18 (2004) 144-151
15. Gómez-Torres M.J., Acién P., Campos A., and Velasco I. Embryotoxicity of peritoneal fluid in women with endometriosis. Its relation with cytokines and lymphocyte populations. Hum. Reprod. 17 (2002) 777-781
16. Hirata T., Osuga Y., Hamasaki K., Yoshino O., Ito M., Hasegawa A., et al. Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygenase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology 149 (2008) 1260-1267
17. Ismail M.A., Rotmensch J., Mercer L.J., Block B.S., Salti G.I., and Holt J.A. CA-125 in peritoneal fluid from patients with nonmalignant gynecologic disorders. J. Reprod. Med. 39 (1994) 510-512
18. Keenan J.A., Chen T.T., Chadwell N.L., Torry D.S., and Caudle M.R. Interferon-gamma (IFN-gamma) and interleukin-6 (IL-6) in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am. J. Reprod. Immunol. 32 (1994) 180-183
19. Keenan J.A., Chen T.T., Chadwell N.L., Torry D.S., and Caudle M.R. IL-1 beta, TNF-alpha, and IL-2 in peritoneal fluid and macrophage-conditioned media of women with endometriosis. Am. J. Reprod. Immunol. 34 (1995) 381-385
20. Koninckx P.R., Muyldermans M., Moerman P., Meuleman C., Deprest J., and Cornillie F. CA 125 concentrations in ovarian 'chocolate' cyst fluid can differentiate an endometriotic cyst from a cystic corpus luteum. Hum. Reprod. 7 (1992) 1314-1317
21. Martínez S., Garrido N., Coperias J.L., Pardo F., Desco J., García-Velasco J.A., et al. Serum interleukin-6 levels are elevated in women with minimal-mild endometriosis. Hum. Reprod. 22 (2007) 836-842
22. Matalliotakis I.M., Goumenou A.G., Mulayim N., Karkavitsas N., and Koumantakis E.E. High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis. Arch. Gynecol. Obstet. 271 (2005) 40-45
23. McLaren J., Dealtry G., Prentice A., Charnock-Jones D.S., and Smith S.K. Decreased levels of the potent regulator of monocyte/macrophage activation, interleukin-13, in the peritoneal fluid of patients with endometriosis. Hum. Reprod. 12 (1997) 1307-1310
24. Mulayim N., Savlu A., Guzeloglu-Kayisli O., Kayisli U.A., and Arici A. Regulation of endometrial stromal cell matrix metalloproteinase activity and invasiveness by interleukin-8. Fertil. Steril. 81 (2004) 904-911
25. Nisolle M., Casanas-Roux F., and Donnez J. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil. Steril. 68 (1997) 912-919
26. Noble L.S., Simpson E.R., Johns A., and Bulun S.E. Aromatase expression in endometriosis. J. Clin. Endocrinol. Metab. 81 (1996) 174-179
27. Noble L.S., Takayama K., Zeitoun K.M., Putman J.M., Johns D.A., Hinshelwood M.M., et al. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J. Clin. Endocrinol. Metab. 82 (1997) 600-606
28. Singh A., Purohit A., Duncan L.J., Mokbel K., Ghilchick M.W., and Reed M.J. Control of aromatase activity in breast tumours: the role of the immune system. J. Steroid Biochem. Mol. Biol. 61 (1997) 185-192
29. Tariverdian N., Theoharides T.C., Siedentopf F., Gutiérrez G., Jeschke U., Rabinovich G.A., et al. Neuroendocrine-immune disequilibrium and endometriosis: an interdisciplinary approach. Semin. Immunopathol. 29 (2007) 193-210
30. Tsudo T., Harada T., Iwabe T., Tanikawa M., Nagano Y., Ito M., et al. Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues. Fertil. Steril. 73 (2000) 205-211
31. Velasco I., Campos A., and Acién P. Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage, and intracystic recombinant interleukin-2. Fertil. Steril. 83 (2005) 873-877
32. Velasco I., Rueda J., and Acién P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Mol. Hum. Reprod. 12 (2006) 377-381
33. Wilson T.J., Hertzog P.J., Angus D., Munnery L., Wood E.C., and Kola I. Decreased natural killer cell activity in endometriosis patients: relationship to disease pathogenesis. Fertil. Steril. 62 (1994) 1086-1088
34. Witz C.A., Montoya I.A., Dey T.D., and Schenken R.S. Characterization of lymphocyte subpopulations and T cell activation in endometriosis. Am. J. Reprod. Immunol. 32 (1994) 173-179
35. Yao Z., Painter S.L., Fanslow W.C., Ulrich D., Macduff B.M., Spriggs M.K., et al. Human IL-17: a novel cytokine derived from T cells. J. Immunol. 155 (1995) 5483-5486
36. Zeitoun D., Takayama K., Sasano H., Suzuki T., Moghrabi N., Andersson S., et al. Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17β-estradiol. J. Clin. Endocrinol. Metab. 83 (1999) 4474-4480
37. Zhang X., Xu H., Lin J., Qian Y., and Deng L. Peritoneal fluid concentrations of interleukin-17 correlate with the severity of endometriosis and infertility of this disorder. B.J.O.G. 112 (2005) 1153-1155